In fact, abnormal elevation and cytoplasmic localization of HuR have been shown in varied kidney diseases such as diabetic nephropathy [19,20], hypertension-related nephropathy [21,22], renal malignancies [23], and ischemia-reperfusion-induced kidney injury [24]. Here, ELAVL1 is linked to diabetic kidney disease.